![]() |
市场调查报告书
商品编码
1631118
美国辐照设备市场规模、份额、趋势分析报告:按类型、应用、最终用途和细分市场预测,2025 年至 2030 年U.S. Irradiation Apparatus Market Size, Share & Trends Analysis Report By Type, By Application, End-use, And Segment Forecasts, 2025 - 2030 |
预计 2024 年美国辐照设备市场价值将达到 28.8 亿美元,2025 年至 2030 年期间复合年增长率为 6.0%。
对非侵入性医疗程序的需求不断增长是辐照设备市场成长的主要驱动力。非侵入性手术通常需要精确的消毒和设备,随着患者和医疗保健提供者寻求传统侵入性方法的替代方法,非侵入性手术越来越受欢迎。此外,核子医学诊断和治疗应用中辐照设备的使用越来越多,进一步推动了市场的成长。
癌症、心血管疾病、肌肉骨骼疾病、摄护腺癌和乳癌等慢性疾病的发生率不断上升,是采用非侵入性诊断解决方案的主要驱动因素。这些疾病需要先进的影像技术,X射线等放射设备被广泛使用。这些设备能够实现早期和准确的诊断,从而无需进行侵入性手术即可及时干预和治疗。此外,到 2022 年,美国癌症患者数量预计将达到 190 万人。据美国癌症协会称,肺癌是最常见的癌症之一,预计仅 2024 年美国出现超过 234,580 例新病例。此外,2022 年美国前列腺癌的发生率和盛行率为 230,125。这一趋势反映了医疗保健领域向非侵入性方法的更广泛转变,这种方法可以改善患者的治疗效果并优先考虑患者的安全和疗效。
核子医学范围的扩大,导致对保证医学影像诊断和治疗高精度的辐照设备的需求日益增加。这一趋势凸显了辐照器在提高美国卫生服务能力方面的重要作用。低分次放射治疗的使用促进了美国放射设备市场的显着成长。这种治疗方法可以在较少的疗程中提供更高剂量的辐射,从而提高患者的依从性和治疗效果,同时降低整体医疗成本。这种方法优化了现有设备的使用,使现有的放射治疗系统更有效率。它也推动了对影像导航放射治疗(IGRT) 和强度调控放射治疗(IMRT) 等先进技术的需求,这些技术对于提供精准有效的治疗至关重要。因此,这些进步和治疗创新正在推动美国辐照设备市场的成长。
此外,强度调控放射治疗影像导航放射治疗治疗和立体定位放射治疗,正在增强癌症治疗。这一趋势有助于增加对患病肿瘤的放射剂量,同时减少对健康组织的影响。例如,2024 年 6 月,赛默飞世尔科技推出了 NetDose PRO,这是一款辐射剂量计,旨在提高测量辐射暴露剂量的安全性和准确性。此剂量计经过NVLAP(国家自愿实验室认可计画)认证,符合高安全标准。 NetDose PRO 旨在改善各种环境中的辐射监测,包括医疗和研究。赛默飞世尔科技 NetDose PRO 辐射剂量计的推出彰显了辐射安全技术的进步,这对于使用辐照器的环境至关重要。
The U.S. irradiation apparatus market size was estimated at USD 2.88 billion in 2024 and is expected to grow at a CAGR of 6.0% from 2025 to 2030. The increasing demand for non-invasive medical procedures is a significant driving factor in the growth of the irradiation apparatus market. As patients and healthcare providers seek alternatives to traditional invasive methods, non-invasive procedures, which often require precise sterilization and equipment, are gaining popularity. Furthermore, the increased usage of irradiation devices in nuclear medicine for diagnostic and therapeutic applications further propels market growth.
The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, musculoskeletal disorders, prostate cancer, and breast cancer is a significant driver for the adoption of non-invasive diagnostic solutions. These conditions necessitate sophisticated imaging techniques, where X-ray and other irradiation apparatus are widely used. Such devices enable early and accurate diagnosis, allowing timely intervention and treatment that does not require invasive procedures. Furthermore, the number of cancer cases in the U.S. reached 1.9 million in 2022. According to the American Cancer Society, lung cancer is one of the most diagnosed cancers, with over 234,580 new cases expected in the U.S. in 2024 alone. Furthermore, the incidence and rate of prostate cancer in 2022 in the U.S. were 230,125. This trend enhances patient outcomes and reflects a broader shift within the healthcare sector toward non-invasive approaches that prioritize patient safety and efficacy.
The expanding scope of nuclear medicine has driven the demand for irradiation equipment that ensures high precision in medical imaging and treatment delivery. This trend underscores the critical role of irradiation apparatus in enhancing the capabilities of healthcare services in the U.S. The usage of hypo-fractionated radiotherapy contributes to notable growth in the U.S. market for irradiation apparatus. This treatment method, which delivers higher doses of radiation over fewer sessions, improves patient adherence and treatment outcomes while reducing overall healthcare costs. This approach optimizes the use of current equipment, making existing radiotherapy systems more efficient. Furthermore, it fuels demand for advanced technologies such as Image-Guided Radiation Therapy (IGRT) and Intensity-Modulated Radiation Therapy (IMRT), essential for delivering precise and effective treatment. Consequently, these advancements and treatment innovations drive market growth for irradiation apparatus in the U.S.
Furthermore, technological innovations in radiation therapies, such as intensity-modulated radiation therapy, image-guided radiation therapy, and stereotactic body radiotherapy, have enhanced cancer treatments. The trend helps to increase the radiation dose to affected tumors and, simultaneously, reduce the effects on the healthy tissues. For instance, In June 2024, Thermo Fisher Scientific launched the NetDose PRO radiation dosimeter, designed to enhance safety and accuracy in measuring radiation exposure. This device is accredited by the National Voluntary Laboratory Accreditation Program (NVLAP), ensuring it meets high safety standards. The NetDose PRO aims to improve radiation monitoring in various settings, including healthcare and research environments. The launch of Thermo Fisher Scientific's NetDose PRO radiation dosimeter highlights advancements in radiation safety technology, which is crucial for environments utilizing irradiation devices.
U.S. Irradiation Apparatus Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. irradiation apparatus market report based on type, application, and end-use: